Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 16,210
+440 (2.79%)
Nov 20, 2025, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 700.93 billion as of November 19, 2025.
Market Cap
700.93B
Enterprise Value
647.52B
Revenue
46.65B
Ranking
n/a
PE Ratio
41.84
Stock Price
16,210.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 700.93B, an increase of 275.01%. That is a compound annual growth rate of 322.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 700.93B | 297.04% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.49T |
| ALTEOGEN | 29.90T |
| SK Biopharmaceuticals | 9.93T |
| ABL Bio | 9.18T |
| Yuhan | 8.97T |
| Peptron | 7.28T |
| LigaChem Biosciences | 6.50T |